Atlantic Healthcare Overview

  • Year Founded
  • 2006

Year Founded

  • Status
  • Private

  • Employees
  • 10

Employees

  • Latest Deal Type
  • Bankr. Admin/​Reorg

Atlantic Healthcare General Information

Description

Developer of specialty pharmaceutical products intended to address unmet patient needs and rare diseases. The company develops and commercializes pharmaceutical products for the treatment of pouchitis and ulcerative colitis, enabling healthcare providers with pharmaceutical products to treat patients suffering from gastrointestinal diseases.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Corporate Office
  • Atlantic House
  • 10 Rose and Crown Walk, Essex
  • Saffron Walden CB10 1JH
  • England, United Kingdom
+44 01799
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Corporate Office
  • Atlantic House
  • 10 Rose and Crown Walk, Essex
  • Saffron Walden CB10 1JH
  • England, United Kingdom
+44 01799

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Atlantic Healthcare Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Bankruptcy: Admin/Reorg 01-Nov-2022 Completed Bankruptcy: Admin/Reorg
6. Later Stage VC 21-Mar-2016 Completed Generating Revenue
5. Later Stage VC 17-Dec-2013 Completed Generating Revenue
4. Grant 18-Mar-2013 Completed Generating Revenue
3. Later Stage VC 04-Apr-2012 Completed Generating Revenue
2. Later Stage VC 17-Aug-2011 $3.38M $3.8M Completed Startup
1. Seed Round $420K $420K Completed Startup
To view Atlantic Healthcare’s complete valuation and funding history, request access »

Atlantic Healthcare Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary
Ordinary
Hurdle
Ordinary
Ordinary
Ordinary
Ordinary
Ordinary
Ordinary 100,850 $0.000709 $20.57 $20.57 1x $20.57 0.34%
Ordinary 1,915 $0.000709 $27.17 $27.17 1x $27.17 0.01%
To view Atlantic Healthcare’s complete cap table history, request access »

Atlantic Healthcare Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Atlantic Healthcare Investments (1)

Atlantic Healthcare’s most recent deal was a Corporate Asset Purchase with EndoLogic (Global Rights to Renzapride). The deal was made on 01-Jul-2019.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
EndoLogic (Global Rights to Renzapride) 01-Jul-2019 Corporate Asset Purchase Buildings and Property
To view Atlantic Healthcare’s complete investments history, request access »

Atlantic Healthcare FAQs

  • When was Atlantic Healthcare founded?

    Atlantic Healthcare was founded in 2006.

  • Where is Atlantic Healthcare headquartered?

    Atlantic Healthcare is headquartered in Saffron Walden, United Kingdom.

  • What is the size of Atlantic Healthcare?

    Atlantic Healthcare has 10 total employees.

  • What industry is Atlantic Healthcare in?

    Atlantic Healthcare’s primary industry is Pharmaceuticals.

  • Is Atlantic Healthcare a private or public company?

    Atlantic Healthcare is a Private company.

  • What is Atlantic Healthcare’s current revenue?

    The current revenue for Atlantic Healthcare is .

  • How much funding has Atlantic Healthcare raised over time?

    Atlantic Healthcare has raised $55.4M.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »